These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 9693387)

  • 1. The spectrum of behaviors influenced by serotonin.
    Lucki I
    Biol Psychiatry; 1998 Aug; 44(3):151-62. PubMed ID: 9693387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple serotonin receptors: clinical and experimental aspects.
    Roth BL
    Ann Clin Psychiatry; 1994 Jun; 6(2):67-78. PubMed ID: 7804391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation.
    Polter A; Yang S; Zmijewska AA; van Groen T; Paik JH; Depinho RA; Peng SL; Jope RS; Li X
    Biol Psychiatry; 2009 Jan; 65(2):150-9. PubMed ID: 18823877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved Serotonergic Background of Experience-Dependent Behavioral Responsiveness in Zebrafish (
    Varga ZK; Pejtsik D; Biró L; Zsigmond Á; Varga M; Tóth B; Salamon V; Annus T; Mikics É; Aliczki M
    J Neurosci; 2020 Jun; 40(23):4551-4564. PubMed ID: 32350040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New lessons from knockout mice: The role of serotonin during development and its possible contribution to the origins of neuropsychiatric disorders.
    Gingrich JA; Ansorge MS; Merker R; Weisstaub N; Zhou M
    CNS Spectr; 2003 Aug; 8(8):572-7. PubMed ID: 12907920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of serotonin manipulations on emotional information processing and mood.
    Merens W; Willem Van der Does AJ; Spinhoven P
    J Affect Disord; 2007 Nov; 103(1-3):43-62. PubMed ID: 17363069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
    Ressler KJ; Nemeroff CB
    Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1).
    Santarelli L; Gobbi G; Blier P; Hen R
    J Clin Psychiatry; 2002; 63 Suppl 11():11-7. PubMed ID: 12562138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dimensional approach to trans-nosographic study of psychotropic drugs].
    Jouvent R
    Encephale; 1995 Feb; 21 Spec No 1():39-43. PubMed ID: 7729355
    [No Abstract]   [Full Text] [Related]  

  • 10. Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders.
    Helton SG; Lohoff FW
    Pharmacogenomics; 2015; 16(5):541-53. PubMed ID: 25916524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic modification of serotonergic function: drugs for the study and treatment of psychiatric and other disorders.
    Fuller RW
    J Clin Psychiatry; 1986 Apr; 47 Suppl():4-8. PubMed ID: 3514585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs.
    Abrams JK; Johnson PL; Hay-Schmidt A; Mikkelsen JD; Shekhar A; Lowry CA
    Neuroscience; 2005; 133(4):983-97. PubMed ID: 15916857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin and psychiatric disorders. A key to new therapeutic approaches.
    Costall B; Naylor RJ
    Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulatory role of serotonin in neural information processing: implications for human psychopathology.
    Spoont MR
    Psychol Bull; 1992 Sep; 112(2):330-50. PubMed ID: 1454898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin receptor changes after chronic antidepressant treatments: ligand binding, electrophysiological, and behavioral studies.
    Anderson JL
    Life Sci; 1983 Apr; 32(16):1791-801. PubMed ID: 6339859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders.
    Malone KM; Waternaux C; Haas GL; Cooper TB; Li S; Mann JJ
    Am J Psychiatry; 2003 Apr; 160(4):773-9. PubMed ID: 12668368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of anxiety circuits by serotonergic systems.
    Lowry CA; Johnson PL; Hay-Schmidt A; Mikkelsen J; Shekhar A
    Stress; 2005 Dec; 8(4):233-46. PubMed ID: 16423712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacologic profile of fluoxetine.
    Stark P; Fuller RW; Wong DT
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):7-13. PubMed ID: 3871767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of serotonin in the behavioral and psychological symptoms of dementia.
    Lanctôt KL; Herrmann N; Mazzotta P
    J Neuropsychiatry Clin Neurosci; 2001; 13(1):5-21. PubMed ID: 11207325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.